Illumina, Inc.
ILMN
주식 순위
#618
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
주가
$262.32
마지막 동기화: 2026-10-16
시가총액
$39.61B
변동 (1일)
-2.09%
변동 (1년)
174.80%
국가
US
거래 Illumina, Inc. (ILMN)
카테고리
Healthcare
Illumina, Inc. (ILMN)의 EPS
June 2026 기준 EPS TTM: $5.41
Illumina, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $5.41입니다. 2024년 말에는 회사의 EPS가 $-7.69였으며, 이는 2023년의 EPS $-7.35와 증가입니다.
Illumina, Inc.의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $5.41 | -1.10% |
| 2025 | $5.47 | -171.13% |
| 2024 | $-7.69 | 4.63% |
| 2023 | $-7.35 | -244.69% |
| 2022 | $5.08 | 13.90% |
| 2021 | $4.46 | -34.60% |
| 2019 | $6.82 | 21.35% |
| 2018 | $5.62 | 13.08% |
| 2017 | $4.97 | 57.78% |
| 2016 | $3.15 | -0.94% |
| 2015 | $3.18 | 21.84% |
| 2014 | $2.61 | 161.00% |
| 2013 | $1.00 | -18.70% |
| 2012 | $1.23 | 75.71% |
| 2011 | $0.70 | -30.69% |
| 2010 | $1.01 | 71.19% |
| 2009 | $0.59 | 37.21% |
| 2008 | $0.43 | -116.73% |
| 2007 | $-2.57 | -671.11% |
| 2006 | $0.45 | -273.08% |
| 2005 | $-0.26 | 199.54% |
| 2004 | $-0.09 | -79.33% |
| 2003 | $-0.42 | -35.38% |
| 2002 | $-0.65 | 54.76% |
| 2001 | $-0.42 | 27.27% |
| 2000 | $-0.33 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $18.62 | 244.18% |
US
|
|
| $5.65 | 4.44% |
US
|
|
| $-1.36 | -125.14% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -5.91% |
US
|
